Biological and Chemical Sensors for Emerging Applications

摘要

Price per Biomarker seems attractive, especially for improved sensitivity. Invest heavily to develop detection platform. Discover challenges of obtaining regulatory approval for high degree of multiplexing. Reduce multiplexing. Cost per Biomarker no longer competitive for clinical lab, but may still have a POC play. Invest heavily to reduce costs, usually by high-volume production. Regardless of cost of biochip, consumable and support system still too expensive and/or complex for POC.